Literature DB >> 8407943

Interleukin-1-induced signaling in T-cells. Evidence for the involvement of phosphatases PP1 and PP2A in regulating protein kinase C-mediated protein phosphorylation and interleukin-2 synthesis.

M Kracht1, A Heiner, K Resch, M Szamel.   

Abstract

Binding of human recombinant interleukin-1 beta (IL-1 beta) to the cell surface receptors of EL-4 6.1 murine T-cells results in enhanced phosphorylation of several cellular proteins. Staurosporine abolished the enhanced phosphorylation in response to IL-1 for some of these proteins, suggesting that protein kinase C (PKC) was at least partially responsible. PKC-beta was translocated from the cytosol to the plasma membrane between 2 and 15 min after IL-1 binding. Activation of PKC-beta was enhanced by the protein phosphatase inhibitor okadaic acid. In fact, okadaic acid inhibited dephosphorylation of the PKC-specific peptide GS (Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ala-Ala-Lys-Lys). On the other hand, okadaic acid also led to elevation of IL-1-induced trans/autophosphorylation of PKC-beta. Accordingly, IL-1 induction of interleukin-2 synthesis was markedly enhanced by okadaic acid in EL-4 cells. These data suggest that activation of PKC-beta contributes to enhanced phosphorylation of cellular proteins in IL-1-treated cells and support the importance of protein phosphorylation and dephosphorylation in the regulation of IL-1-induced IL-2 synthesis in EL-4 6.1 T-cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407943

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Staurosporine, but not Ro 31-8220, induces interleukin 2 production and synergizes with interleukin 1alpha in EL4 thymoma cells.

Authors:  T M Mahon; J S Matthews; L A O'Neill
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Human- and mouse-inducible nitric oxide synthase promoters require activation of phosphatidylcholine-specific phospholipase C and NF-kappa B.

Authors:  S V Spitsin; J L Farber; M Bertovich; G Moehren; H Koprowski; F H Michaels
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

3.  Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration.

Authors:  T Dubois; J P Mira; D Feliers; E Solito; F Russo-Marie; J P Oudinet
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

4.  Interleukin 1-beta-induced protein kinase C-zeta activation is mimicked by exogenous phospholipase D.

Authors:  C Limatola; B Barabino; A Nista; A Santoni
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

5.  Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus.

Authors:  Christina G Katsiari; Vasileios C Kyttaris; Yuang-Taung Juang; George C Tsokos
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

6.  Human T-cell lymphotropic virus type 1 Tax1 activation of NF-kappa B: involvement of the protein kinase C pathway.

Authors:  P F Lindholm; M Tamami; J Makowski; J N Brady
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  Interleukin-1 activates a novel protein kinase that phosphorylates the epidermal-growth-factor receptor peptide T669.

Authors:  M Kracht; M Shiroo; C J Marshall; J J Hsuan; J Saklatvala
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

8.  Methylation status of CpG islands flanking a cAMP response element motif on the protein phosphatase 2Ac alpha promoter determines CREB binding and activity.

Authors:  Katsue Sunahori; Yuang-Taung Juang; George C Tsokos
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

Review 9.  Systemic lupus erythematosus: new molecular targets.

Authors:  José C Crispín; Vasileios Kyttaris; Yuang-Taung Juang; George C Tsokos
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.